Pharmacogenomic research in South Africa: lessons learned and future opportunities in the rainbow nation
South Africa, like many other developing countries, stands to benefit from novel diagnostics
and drugs developed by pharmacogenomics guidance due to high prevalence of disease …
and drugs developed by pharmacogenomics guidance due to high prevalence of disease …
Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity
Aim: The frequencies of variants of pharmacogenetic importance differ across populations.
African populations exhibit the greatest genetic heterogeneity, cautioning against …
African populations exhibit the greatest genetic heterogeneity, cautioning against …